Search research articles
Contact Us
Filters
Showing results (21-30 of 24) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 24 results.
Infection and Immunity
|
June 23, 2006
Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and toll-like receptor 4-dependent pathways
A Grabig, D Paclik, C Guzy, et al.
Alimentary Pharmacology & Therapeutics
|
September 20, 2007
Heterozygosity for IL23R p.Arg381Gln confers a protective effect not only against Crohn's disease but also ulcerative colitis
C Büning, H H-J Schmidt, T Molnar, et al.
Alimentary Pharmacology & Therapeutics
|
October 8, 2016
Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease - a prospective multicenter observational study
A Stallmach, C Langbein, R Atreya, et al.
Journal of Crohn'S & Colitis
|
April 16, 2013
Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines
J Panes, Y Bouhnik, W Reinisch, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 24) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 24 results.
Infection and Immunity
|
June 23, 2006
Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and toll-like receptor 4-dependent pathways
A Grabig, D Paclik, C Guzy, et al.
Alimentary Pharmacology & Therapeutics
|
September 20, 2007
Heterozygosity for IL23R p.Arg381Gln confers a protective effect not only against Crohn's disease but also ulcerative colitis
C Büning, H H-J Schmidt, T Molnar, et al.
Alimentary Pharmacology & Therapeutics
|
October 8, 2016
Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease - a prospective multicenter observational study
A Stallmach, C Langbein, R Atreya, et al.
Journal of Crohn'S & Colitis
|
April 16, 2013
Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines
J Panes, Y Bouhnik, W Reinisch, et al.
Page
of 3